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                                                          INTRODUCTION
                                     Definite diagnosis of  coronary occlusion can  be made by coronary angiography 
(CAG).  However,  it  is  an  invasive  technique and  only available  in  the  catheterization  laboratory. 
Patients without anginal symptoms, left ventricular dysfunction or electrocardiographic  changes may 
not be diagnosed until cardiac events occur. If noninvasive detection of total coronary occlusion before 
CAG becomes possible, it could help in the consideration of further invasive procedures and in the 
estimation of the results of various interventions.
                               Coronary flow velocity measurements have provided useful clinical and physiologic 
information.  They have  been  assessed by several  Doppler  techniques  with  a  Doppler  catheter,   a 
Doppler guidewire , an epicardial probe  and a transesophageal probe . Doppler catheter  and a Doppler 
guidewire  are   already have  been  validated  for  the  measurement  of  Coronary flow velocity  and 
established as useful techniques in the clinical setting. However, they are invasive.. Transesophageal 
Doppler echocardiography is semiinvasive,. Thus, it has been difficult to apply assessment of CFV to 
patients in routine clinical practice. 
Transthoracic Doppler echocardiography is noninvasive, relatively inexpensive and widely used in the 
clinical setting, and can be used for serial studies in echocardiographic laboratories. Several studies 
have reported that CFV can be measured by visualizing LAD using transthoracic two-dimensional and 
Doppler echocardiography with a high-frequency transducer . It has been also  shown that CFV in the 
distal LAD can be measured at high success rate by TTDE under the guidance of color Doppler flow 
mapping, and assessment of CFVR in the LAD by this noninvasive technique is useful in the diagnosis 
of significant LAD stenosis . 
                                                  AIM
 To determine whether the coronary flow velocity pattern  assessed by Transthoracic Colour 
Doppler  Echocardiography  serves  as  a  predictor  of  significant  Left  Anterior  Descending 
coronary artery stenosis.
 To evaluate the value of coronary flow velocity  reserve determined by Transthoracic Colour 
Doppler  Echocardiography  for  the  assessment  the  degree  of  severity  of   Left  Anterior 
Descending coronary artery stenosis.
 To  compare   coronary  flow  velocity  pattern   assessed  by  Transthoracic  Colour  Doppler 
Echocardiography   and  Exercise  stress  testing  with  Treadmill  to  predict  significant  Left 
Anterior Descending coronary artery stenosis.
                                                 REVIEW OF LITERATURE 
Atherosclerotic coronary stenosis is the most common cause of myocardial ischemia. Based on data 
from the Framingham Heart Study, the lifetime risk of developing symptomatic CAD after age 40 is 49 
percent for men and 32 percent for women. Ischemic heart disease is now the leading cause of death 
worldwide. The World Health Organization estimates that by 2020 the global number of deaths from 
CAD will have risen from 7.1 in 2002 to 11.1 million 1.
                                                              Different clinical ischemic syndromes result from fixed obstruction to coronary 
blood flow by atherosclerotic plaques or thrombosis,or by abnormal epicardial coronary vasomotion,or 
by  microvascular  dysfunction.  These  events  can  occur  together  or  separately.  Understanding  the 
coronary circulatory physiology  aids physicians to diagnose and treat these events effectively.  
DIAGNOSIS OF CORONARY ARTERY DISEASE 
                                                         Definite diagnosis of  coronary stenosis can  be made by coronary 
angiography (CAG). However,  it  is an invasive technique and only available in the catheterization 
laboratory.  Patients without  anginal  symptoms,  left  ventricular  dysfunction  or  electrocardiographic 
changes may not be diagnosed until cardiac events occur. If noninvasive detection of  coronary stenosis 
before CAG becomes possible, it could help in the consideration of further invasive procedures and in 
the estimation of the results of various interventions.
                Many noninvasive methods like Exercise stress testing, Stress Echocardiography, Nuclear 
imaging and CT angiography  can aid in prediction of coronary stenosis.Each has different sensitivity 
and specificity to predict coronary stenosis  in relation to stenosis  diagnosed by coronary angiogram as 
a gold standard investigation.
                         
   ANGIOGRAPHIC ASSESSMENT OF CORONARY ARTERY NARROWINGS:
 An  angiographic  lumen  narrowing  is  commonly  referred  to  as  a  stenosis  which  may be  due  to 
atherosclerosis, vasospasm, or angiographic artifact.
To quantify the coronary stenosis accurately it must be seen in profile, free from artifact related to 
foreshortening or  obfuscation by a  crossing vessel.    Multiple  views are  important,  because many 
lesions have a markedly eccentric lumen. When seen across its major axis, the width of the lumen may 
appear to be normal, but a clue to the presence of a severe degree of narrowing in the other axis may be 
marked lucency caused by thinning of the contrast column. 
The  normal  caliber  of  major  coronary  arteries,  Left  main  4.5±0.5mm,LAD  3.7±0.4mm,  LCX 
3.4±0.5mm for non dominant and dominant LCX 4.2 ±0.6mm; RCA 3.9 ± 0.6 for dominant and 2.8 ± 
0.5 for non dominant.
By comparing the diameter of a presumably disease free segment of coronary artery to the size of the 
diagnostic catheter (6F equals 2mm), the operator can identify vessels that fall below these normal size 
ranges  and  may  thus  be  diffusely  diseased.  The  evaluation  stenosis  relates  to  the  percentage  of 
reduction in the diameter of narrowed vessel site to the adjacent unobstructed vessel.  The diameter 
stenosis is calculated in the projection where the greatest narrowing is seen.   It should be noted that the 
stenotic  lumen  is  compared  to  near  by  unobstructed  lumen,  which  indeed  may  have  diffuse 
atherosclerotic  disease and thus  is  angiographically normal  but  still  may be  diseased.  The  area of 
stenosis is always greater than diameter stenosis and assumes the lumen is circular when in reality most 
of the time the lumen is eccentric.
A 50 % of reduction in diameter is equivalent to a 75% reduction in Cross Sectional area, and a 75% 
reduction diameter is equal to a 90 % reduction in cross sectional area.  Stenosis that reduces the lumen 
diameter by 50% (and hence cross sectional area by 75%) is hemodynamically significant, in that it 
reduces the normal three fold to four fold flow reserve of coronary bed.  
Whereas a  diameter  stenosis  of 70% (90% cross  sectional  area)  eliminates virtually any ability to 
increase flow above it's resting level.  Stenosis that reduced the lumen diameter by 90%, however, 
rarely exists  without  reducing  antegrade  flow.  Because  of  the  subjective  nature  of  a  visual  lesion 
assessment, there is a ± 20% variation between readings of two or more experienced angiographers 
especially for lesions 40 – 70% narrowed.
The simplest way to resolve this problem is, project the coronary image on a wall mounted viewing 
screen,  and  use  inexpensive  digital  calipers  to  measure  the  relative  diameters  of  the  stenotic  and 
reference  segment.   Percent  stenosis  can  be  calculated  as  100  ×  (1  –  stenosis  diameter/reference 
diameter) to provide a more accurate estimate of stenosis.  
TIMI FRAME COUNT 
                       Myocardial blood flow has been assessed angiographically using Thrombolysis in 
Myocardial infarction (TIMI) score for qualitative grading of coronary flow.   TIMI flow grades 0 – 3 
have  become  a  standard  description  of  angiographic  coronary  blood  flow  in  clinical  trails. 
Quantitative method of TIMI uses cine angiography with 6F catheters and filming at 30 frames per 
second  .The  number  of  cine  frames  from  the  introduction  of  dye  in  the  coronary  artery  to 
predetermined distal landmark is counted.
          The first frame used for TIMI frame counting is that in which the dye fully opacifies the artery 
origin  and  in  which  the  dye  extends  across  the  width  of  the  artery  touching  both  borders  with 
anterograde motion of the dye. The last frame counted is when the dye enters the first landmark branch. 
Full opacification of distal branch not required. The distal landmark commonly used in analyses are,
(1) for LAD -the distal bifurcation of LAD. 
(2) for the circumflex system ,the distal bifurcation of branch segments with the longest total distance.
(3) for the RCA the first branch of posterolateral artery.
The TIMI frame count can further be quantified for the length of the LAD for comparison to the two 
other major arteries. This is called corrected TIMI frame count (CTFC). The average LAD coronary 
artery is 14.7cm long, RCA 9.8cm, LCX 9.3cm. CTFC accounts for the distance the dye has to travel in 
the  LAD relative to  the other  arteries.  CTFC divides  the absolute  frame count  in  LAD by 1.7 to 
standardise the distance of dye travel in all the three arteries. Normal TFC for LAD is 36±3 and CTFC 
21±2, for LCX TFC is 22±4, for RCA TFC is 20±3. TIMI flow grades do not correspond to measured 
Doppler flow velocity or CTFC. High TFC may be associated with microvascular dysfunction despite 
an open artery.  CTFC of <20 frames were associated with low risk for adverse events in  patients 
following myocardial infarction. A contrast injection rate of >1ml/sec by hand injection can decrease 
the  TIMI frame count  by 2 frames.  The TIMI frame count  method provides  valuable  information 
relative to clinical responses after coronary intervention.
COLLATERAL CIRCULATION
                         The reopacification of a totally or subtotally (99%)occluded vessel from antegrade or  
retrograde filling is defined as collateral filling... Angiographically visible collateral channels are not 
usually seen until  the coronary obstruction is  greater than 90%, at  which point coronary perfusion 
pressure  falls  substantially  and  the  blood  flow  through  the  collaterals  increases.The  collateral 
circulation may provide upto 50% of  anterograde coronary flow in chronic total occlusions. 
PHYSIOLOGY OF CORONARY CIRCULATION:
                   The flow through the coronary arteries is pulsatile, with characteristic phasic systolic and 
diastolic  flow  components.  Systolic  compression  of  the  intramural  coronary  vessels  causes  mean 
systolic arterial flow to be reduced relative to diastolic flow, despite having a higher systolic driving 
pressure. 
          The systolic flow wave has rapid, brief retrograde responses corresponding to phasic myocardial 
compliance over the cardiac cycle.  Diastolic flow occurs during the relaxation phase after myocardial 
contraction with an abrupt increase above systolic levels and a gradual decline parallel with that of 
aortic diastolic pressure.The coronary blood flow not only is phasic but also varies with the type of 
vessel and location in the myocardium. 
              A system of multiple functional "valves" permits fine control of the coronary circulation. The 
smallest  arterioles dilate during metabolic  stress,  resulting in reduced microvascular  resistance and 
increased  myocardial  perfusion.  As  the  upstream arteriolar  pressure  decreases  owing  to  a  fall  in 
distending pressure across a stenosis, myogenic dilation of slightly larger arterioles upstream occurs 
and causes an additional decrease in resistance. Increased flow in the largest arterioles augments shear 
stress  and  triggers  flow-mediated  dilation,  further  reducing  the  resistance  of  this  network.  Thus, 
coronary arterioles appear to have specialized regulatory elements along their length that operate "in 
series" in an integrated manner. 
INFLUENCE OF A STENOSIS ON CORONARY BLOOD FLOW
                         Resistance to flow changes exponentially with lumen cross-sectional area  and linearly 
with lesion length. Additional factors contributing to resistance include the shape of the entrance and 
exit orifices, vessel stiffness, and distensibility of the diseased segment (permitting active or passive 
vasomotion) and the variable lumen obstruction that may be superimposed by platelet aggregation and 
thrombosis compromising lumen area, a process active in acute coronary syndromes.
                     The physiological effect of a coronary stenosis also depends on the degree to which the 
resistance to flow can be compensated by dilation of the microcirculation distal to the stenosis. Resting 
coronary flow is not impeded by mild or moderate stenoses and is maintained by normal vasodilatory 
regulation of the microcirculation. 
                    Resting coronary blood flow remains constant up to the point where an epicardial coronary 
constriction exceeds 85 to 90 percent of the normal segment diameter.However, unlike resting flow, 
maximal hyperemic coronary blood flow begins to decline when diameter stenosis exceeds 45 to 60 
percent. 
                The capacity to increase coronary blood flow in response to a hyperemic stimulus, called 
coronary flow reserve (CFR), is abolished when diameter stenosis exceeds 90 percent. 
CORONARY PRESSURE AND FLOW FOR THE PHYSIOLOGICAL ASSESSMENT OF A 
CORONARY STENOSIS
                The hemodynamic significance of a given stenosis in humans can be measured by the 
pressure-flow relationship using sensor angioplasty guidewires. 
              Three types of stimuli have been used to elicit maximal coronary blood flow in humans: (1) 
transient  coronary  occlusion  during  angioplasty  (reactive  hyperemia);  (2)  pharmacological 
vasodilators;  and  (3)  metabolic  stress  Reactive  hyperemia  follows  an  occlusion  as  short  as  200 
milliseconds. Maximal reactive hyperemia follows coronary occlusion of 20 seconds. Longer occlusion 
increases  the  duration  but  not  the  amplitude  of  the  hyperemic  response.  At  maximal  hyperemia, 
autoregulation is also abolished and coronary blood flow is directly related to the driving pressure. 
                            Adenosine, dipyridamole, and papaverine are the principal pharmacological  
vasodilators used to elicit coronary hyperemia. 
                                    CORONARY FLOW RESERVE (CFR) 
CFR is defined as a ratio of maximal   to  baseline (resting) coronary blood flow.. CFR measurement is 
used both to assess epicardial coronary stenoses and to examine the integrity of micro vascular 
circulation.. In the absence of stenosis in epicardial coronary artery,the CFR may be decreased when 
coronary micro vascular circulation is compromised by arterial hypertension with or without left 
ventricular hypertrophy, diabetes mellitus, hypercholesterolemia, syndrome X, hypertrophic 
cardiomyopathy or other diseases1.
 
                                            METHODS TO ASSESS CFR
                                CFR measures the ability of the two components of myocardial perfusion, namely 
the epicardial stenosis resistance and the microvascular resistance, to achieve maximal blood flow. 
                               There are two invasive methods available to measure coronary blood flow in the 
catheterization  laboratory:  intracoronary  Doppler  flow  velocity  and  coronary  thermodilution. 
Volumetric flow is the product of vessel area (square centimeters) and flow velocity (centimeters per 
second) yielding a value in cubic centimeter per second. The coronary thermodilution technique uses 
thermistors  on  a  pressure-sensor  angioplasty  guidewire  and  measures  the  arrival  time  of  room 
temperature saline bolus  indicator  injections  through the guiding catheter  into the coronary artery. 
When combined with poststenotic pressure measurements, CFR measurements can provide a complete 
description of the pressure-flow relationship and the response of the microcirculation. 
                     Normal CFR in young patients with normal arteries by intravascular ultrasound commonly 
exceeds  3.0.  In  patients  with  chest  pain  undergoing  cardiac  catheterization  with  angiographically 
normal  vessels,  the  CFR  averages  2.7  ±  0.6.   Tachycardia  increases  basal  flow,  reducing  CFR. 
Increasing mean arterial pressure reduces maximal vasodilation, reducing hyperemic flow more than 
basal  flow.  CFR  may  be  reduced  in  patients  with  normal  coronary  arteries  who  have  essential 
hypertension or aortic stenosis. Diabetes mellitus also reduces CFR, especially in patients with diabetic 
retinopathy
                     Several methods have been established for measuring CFR . However, these methods are 
either invasive (intracoronary Doppler flow wire), highly expensive and scarcely available (Positron 
Emission  Tomography)  or  semiinvasive  and  scarcely  feasible  (transesophagealDoppler),  thus  their 
clinical  use  is  limited.  In  addition,  PET  and  intracoronary  Doppler  flow  wire  involve  radiation 
exposure,  with  inherent  risk,  environmental  impact  and  biohazard  connected  with  use  of  ionizing 
testing.
 
NONINVASIVE  ASSESSMENT  OF  CORONARY  FLOW  VELOCITY  RESERVE  WITH 
TRANSTHORACIC COLOR DOPPLER ECHOCARDIOGRAPHY
                             Transthoracic coronary Doppler ultrasound turns our attention from surrogate 
markers of atherosclerosis, such as brachial/ankle index, left ventricular mass, and carotid intima/media 
thickness to a direct screening modality of coronary flow
THE WINDOW 
Coronary  blood  flow  velocity  should  be  measured  from  an  apical  window  by  pulsed  Doppler 
ultrasound under  colour-coding  guide.  The  best  long axis  view in colour  flow imaging should  be 
obtained to maintain a <30 degree angle between flow and the Doppler beam. Correction for the theta 
angle may be used,5–7 but it is a redundant operation, since CFVR is not an absolute, but a derived 
value (ratio between hyperaemic and baseline coronary blood flow velocity). 
 METHODOLGY. 
The TTDE examinations were performed with color Doppler flow mapping, the velocity range was set 
at ±9.6 to 28.8 cm/s. The color gain was adjusted to provide the optimal images.
The transducer was placed at the fourth or fifth intercostal space the cardiac apex and the parasternal 
area the anterior interventricular groove was visualized in the short-axis view.,. In the short-axis images 
of the left ventricle, the mid-portion of the LAD can be identified as a cross section of the tubular 
structure containing the color Doppler flow signal, positioned in the anterior interventricular sulcus.. 
After confirming its position, the transducer was rotated counterclockwise to visualize the LAD, which 
runs along the interventricular sulcus, in the long-axis section while color Doppler flow with a Nyquist 
limit of ±19 to ±24 cm/s was applied to visualize the LAD flow with relatively low velocity; After 
positioning a sample volume (1.5 to 2.5 mm wide) on the color signal in the LAD, Doppler spectral 
tracings  of  flow  velocity  were  recorded  by  the  pulsed  Doppler  method.  Transducer  position  and 
direction were adjusted to make the Doppler beam as parallel as possible to LAD flow, and an angle 
correction was performed Angle correction was needed in each examination (incident angle 41 ± 11°). 
All studies were recorded on s-VHS videotape. Using the computer analysis system incorporated in the 
ultrasound system, off-line measurements of mean diastolic  velocities and peak diastolic  velocities 
were performed by tracing the contour of the spectral Doppler signal.
Flow velocity recordings were performed in a stable transducer position at rest and during maximal 
hyperemia, which was induced by intravenous administration of adenosine (140µg/kg/min). Systolic-
diastolic average peak velocities at rest and during maximal hyperemia (mean peak velocity) were used 
for off-line analysis of spectral Doppler tracings to calculate CFR. The values of three consecutive 
beats were averaged to calculate the flow velocity at rest and during hyperaemia . When the distal LAD 
flow was retrograde by color Doppler or was not visualized within 5 minutes, antegrade LAD flow was 
considered to be absent, and the TTDE coronary study was discontinued 
The sampling site is critical for correct coronary flow measurements because the results may be very 
different when CFVR is measured proximal to the stenosis, at the level of the stenosis or distal to it. 
Proximal to the stenosis, CFVR may be perfectly normal, as it reflects perfusion in normal territories . 
It may be altered only in the rare case there are no side branches between the sampling site and the 
stenosis. 
This is one of the reasons why transoesophageal echocardiography, which allows imaging of the left 
main and the very initial tract of the LAD, has been abandoned for the study of CFVR in CAD. 
At the level of the stenosis, baseline coronary flow accelerates to 40–50 cm/s or more to compensate 
for lumen loss and maintain the coronary output constant. 
This accelerated baseline flow prevents reliable calculation of CFVR. 
Coronary flow should therefore be measured at the distal tract of the coronary artery for three 
reasons, (1) The effect of flow acceleration from a proximal 
or mid coronary stenosis is minimal (2) The cumulative effect of sequential stenoses can be assessed, 
because all  end in alteration of distal  flow; (3) Compared to the proximal and middle tract  of the 
coronary artery,  the capacitance of the distal  tract  is  minimal,  and changes in velocity best reflect 
changes in vital, intramural flow.24
BASELINE FLOW VELOCITY 
Myocardium can incur only a small oxygen debt, and myocardial oxygen consumption is strictly flow-
dependent. For this reason, baseline coronary blood flow may be readjusted on a beat-by-beat basis, 
and baseline coronary flow velocity may change from one beat to the other of even 5–10 cm/s.
 It is therefore important, in case of significant variability of baseline flow velocities, to average values 
obtained from at least three beats, in order to prevent misinterpretations. 
Elevated resting flow velocities may occur in several cardiac and non-cardiac conditions increasing 
oxygen consumption at rest,  including tachycardia, anaemia,hyperthyroidism, severe left ventricular 
hypertrophy, valvular diseases, etc. 
On the other hand, coronary vasodilators such as nitrates or calcium antagonists increase the diameter 
of  the  epicardial  artery  and  reduce  baseline  flow  velocity.  B-Blockers  may  also  reduce  baseline 
coronary  flow  velocity,  mainly  by  decreasing  heart  rate  and   blood  pressure,  and  hence  oxygen 
consumption. 
Adenosine  and  Doppler  Hyperaemic  flow  is  obtained  by  venous  infusion  of  adenosine  (140 
lcg/kg/min), a pure and strong dilator of the coronary microcirculation, having little or no effect on the 
epicardial artery. 
ADENOSINE 
Adenosine, the most commonly used agent in the catheterization laboratory, can be administered by the 
intravenous or intracoronary route.
                RF Wilson et  al  investigated in humans the effects  of adenosine,  administered by 
intracoronary  bolus  (2-16  micrograms),  intracoronary  infusion  (10-240  micrograms/min),  or 
intravenous infusion (35-140 micrograms/kg/min) on coronary and systemic hemodynamics and the 
electrocardiogram. Coronary blood flow velocity (CBFV) was measured with a 3F coronary Doppler 
catheter. 
Intracoronary  infusions  of  80  micrograms/min  or  more  into  the  left  coronary  artery   also  caused 
maximal  hyperemia,  and  doses  up  to  240  micrograms/min  caused  a  minimal  decrease  in  arterial 
pressure (-6 +/- 2 mm Hg) and no significant change in heart rate or in electrocardiographic variables.
 Intravenous infusions in normal patients  at  140 micrograms/kg/min caused coronary vasodilation 
similar to that caused by papaverine. At submaximal infusion rates, however, CBFV often fluctuated 
widely. During the 140-micrograms/kg/min infusion, arterial pressure decreased 6 +/- 7 mm Hg, and 
heart rate increased 24 +/- 14 beats/min..
                     MJ Kern et al showed  that  coronary blood flow velocity were measured at rest and 
during  peak  hyperemic  responses  to  continuous  intravenous  adenosine  infusion  (50,  100  and  150 
micrograms/kg per min for 3 min) and intracoronary papaverine (10 mg) and  after low dose (2.5 mg) 
intravenous bolus injection of adenosine. The maximal adenosine dose did not change mean arterial 
pressure  but increased the heart rate. ... Intracoronary boluses caused a small, brief decrease in arterial 
pressure (similar to that caused by papaverine) and no changes in heart rate or in the electrocardiogram. 
The duration of hyperemia was much shorter  after adenosine than after  papaverine administration.. 
Low dose bolus injection of adenosine increased mean velocity equivalently to that after continuous 
infusion of 100 micrograms/kg, but less than after papaverine. There was a strong correlation between 
adenosine infusion and papaverine for both mean coronary flow velocity and coronary vasodilator 
reserve ratio. No patient had significant arrhythmias or prolongation of the corrected QT (QTc) interval 
with adenosine, but papaverine increased the QT (QTc) interval .
        Adenosine is benign in the appropriate dosages (20 to 30 µg in the right coronary artery or 30 to 
50 µg in the left coronary artery or infused intravenously at 140 µg/kg/min) . Intravenous dobutamine 
(10 to 40 µg/kg/min) can also produce maximal hyperemia without modifying the angiographic area of 
the epicardial stenosis.                         
Coronary flow is  the product  of velocity and the cross-sectional area of the vessel.    Because the 
diameter of the epicardial artery does not change significantly during adenosine infusion , velocity can 
be used as an acceptable surrogate of flow. This is an important prerequisite for any drug used to study 
CFVR, because according to the Poiseuille’s law, even small variations in calliper may cause large 
variations in velocities and hence in flow. Compared to dipyridamole, adenosine is more potent and 
more versatile, as it can be repeatedly infused just after coronary flow velocity returns to baseline. 
SAFETY 
It  is  better  to  infuse  adenosine  for  no  more  than  90  s,  for  three  main  reasons:  (1)  the  maximal 
hyperaemic effect is already reached at 30–60 s; (2) short infusion times prevent the development of 
myocardial ischaemia, which may occur for more prolonged infusion; (3) the costs are significantly 
reduced. Small bolus injection is safe and effective. 
              The adenosine dose may actually be reduced to a minimum of 2.5 mg bolus injection, which 
produces an increase in CFVR similar to that obtained by 3 min venous infusion, and has no significant 
side-effects,40 with important practical and economical implications.
 According to Voci et al, in his series of more than 1000 patients studied with either short infusion or 
bolus injection, including those with acute coronary syndromes, there was only one episode of transient 
atrial fibrillation in a patient with poor left ventricular function and recurrent episodes of paroxysmal 
atrial fibrillation. Nevertheless, some authors still use infusion times of up to 5–6min, which may cause 
significant side-effects, and may result in myocardial ischaemia in critical patients5–7. 
IS THERE A ROLE FOR SYSTOLE? 
It may be difficult to record both diastolic and systolic flow in the same cardiac cycle in all patients, 
because rotational  and  translational  movements  of  the  heart  displace  the  coronary artery from the 
ultrasound beam in systole. However, compared to the diastolic, systolic flow is a less important and 
less stable measure. 
             Diastolic flow is anterograde in both epicardial and intramural vessels, whereas systolic flow is  
anterograde in epicardial but retrograde in intramural vessels, where blood is squeezed backwards by 
myocardial contraction. As a result of the two opposite forces, the magnitude of systolic flow velocity 
may change along the coronary tree and close to the origin of a perforator there might be a watershed 
area with stagnation of systolic flow.16 Therefore, the epicardial anterograde systolic flow is mainly a 
capacitance, rather than a nutrient flow, and does not reflect myocardial perfusion. 
DIAGNOSIS OF SIGNIFICANT CORONARY STENOSIS:  
                              CFVR reflects the impact on total coronary resistances of: (1) The patency of the 
epicardial coronary artery, and (2) The vasodilator capacity of the microcirculation.
 In normal coronary arteries, CFVR entirely describes the resistances of the microcirculation. A flow-
limiting  stenosis  introduces  a  strong  proximal  resistance  that  is  higher  than  that  opposed  by  the 
microcirculation, as demonstrated by the early normalization of CFVR after the mechanical relief of 
the  stenosis  by  coronary  stenting.11  Therefore,  the  impact  of  microcirculation  on  CFVR  is  of 
secondary importance, compared to that of a significant epicardial stenosis. 
             Lance Gould established in his seminal experimental work that a CFVR of 2 discriminates 
significant (P70%) from non-significant (<70%) coronary stenoses.28,29. 
                                 Human studies using single photon emission computed tomography 30 and 
intracoronary45 and transthoracic coronary Doppler ultrasound 3–8, have confirmed these findings, and a 
cut-off  value  of  2  has  been  widely  adopted  as  the  ‘‘magic  number’’  discriminating  significant 
impairment of coronary flow that should be treated invasively by mechanical removal of the stenosis.  
                       Translated into clinical practice, transthoracic coronary Doppler ultrasound helps  
deferring revascularization in patients with CFVR above 2, with important economical, ethical and 
social implications.
                                In keeping with the experimental findings, 28 29 transthoracic coronary Doppler 
ultrasound  correlates  well  with  the  angiographic  degree  of  the  stenosis.3–8, This  is  true  for  non-
significant  (<50%)  and  significant  (P70%)  coronary  lesions,  but  data  on  intermediate  (50–69%) 
lesions10 are more dispersed. 
                         This is not surprising, since intermediate lesions are difficult to quantify even with  
quantitative coronary angiography, which in fact cannot reliably predict the physiological impact of 
these stenoses. In intermediate stenoses, coronary Doppler ultrasound may guide our clinical decision 
making, reserving percutaneous coronary interventions only to patients with reduced CFVR.47. 
             Transthoracic coronary Doppler ultrasound has several advantages over other stress tests: 
        (1) It is accurate in detecting single vessel disease,17,19 However, with the currently available 
technology, transthoracic coronary Doppler ultrasound cannot detect branch stenosis; 
      (2) It is less time consuming, because theoretically only few baseline and hyperaemic diastoles are 
needed to measure CFVR; 
       (3) It provides a quantitative measure of coronary blood flow, which is particularly useful for 
follow-up evaluation;13
       (4) It is independent of baseline ST alterations and bundle branch block; 
       (5) Drugs such as b-blockers may not be discontinued.35 
INTERMEDIATE STENOSIS
                        Understanding the functional impact of stenosis is important for clinical decision 
making. One example is whether to refer or defer patients with intermediate stenosis for percutaneous 
transluminal coronary angioplasty (PTCA).CFR measured distal to the stenosis precisely defines the 
hemodynamic significance of stenosis. In studies using transthoracic Doppler echocardiography, CFR 
<2 is associated with stress-induced ischemia and reduced CFR is considered as a manifestation of 
functionally  important  stenosis  even if  coronary angiography reveals  intermediate  severity5  6  11.  In 
contrast,  patients  with  intermediate  stenosis  but  with  adequate  CFR  value,  PTCA  can  be  safely 
deferred.
The measurement of CFR by transthoracic Doppler echocardiography provides data equivalent to those 
obtained by thallium-201 scintigraphy for physiologic estimation of the severity of LAD stenosis.
  CRITICAL LAD STENOSIS:
              The Coronary Artery Surgery Study registry states that patients with >90% stenosis have a 3–
7.5 times higher probability to develop acute myocardial infarction than those with less severe lesions. 
Unfortunately,  neither  the  clinical  presentation,  nor  the  currently  available  non-invasive  tests  can 
reliably discriminate severe from non-severe stenosis. Using transthoracic Doppler echocardiography, 
it is possible to detect severe LAD stenosis >90%. The CFR <1, which suggests coronary steal may be 
a predictor of critical coronary stenosis23. Coronary steal is defined as a decrease of CFR to a certain 
vascular region in favor of another area during maximal coronary vasodilatation, that is, CFR <1.
Lance Gould  showed that the hyperaemic response disappears at 90% vessel stenosis.37,38  a damped 
CFVR during adenosine infusion is consistently found in patients with severe LAD stenosis.39    Three 
main mechanisms may be proposed to explain, isolated or in combination, why coronary flow cannot 
increase or may actually drop during adenosine infusion in severe stenoses: 
              (1) In extremely tight stenoses, the microvascular reserve may already be exhausted at rest, 
because of maximal peripheral vasodilation, and cannot increase any further under stress;
              (2) An incompletely calcified coronary stenosis may maintain some degree of elasticity and 
may collapse during adenosine infusion37,38  for a drop in intraluminal distending pressure induced by 
flow acceleration at the stenosis site (Venturi effect);
             (3) Pre-stenotic collaterals may open at stress, stealing blood from the ischaemic territory to 
perfuse other less jeopardized segments.58 
      Other authors have postulated that a relative increase in systolic velocity at rest is a marker of 
severe stenosis.40Further studies are needed to confirm the diagnostic value of this parameter, which 
has the limits described above for systolic flow, but the advantage of being obtained with a simple 
resting exam. 
CHRONIC TOTAL OCCLUSION 
   Reverse diastolic flow at rest,  reflecting retrograde filling of the artery by collaterals,  is a very 
specific marker of coronary occlusion41  but it unfortunately has a low sensitivity, since collaterals may 
perfuse the vessel either retrogradely or anterogradely. 
   The collateral flow is routinely evaluated at rest with coronary angiography42 but the predictive role 
of  this  method  is  uncertain.  Conversely,  the  response  of  collateral  flow  to  stress,  which  can  be 
measured  by  intracoronary  and  transthoracic  Doppler  ultrasound,  may  add  useful  prognostic 
information. 
      In his experience, according to Voci et al, it is feasible to measure CFVR in the PD in around 50% 
of the patients regardless of its origin from the right or circumflex coronary artery,12 but others have 
reported higher figures.15 
     The lower success rate of imaging the PD compared to the LAD (feasibility 98%) depends on two 
factors: (1) The PD runs deep into the chest (7–8 cm) while the LAD is more superficial (<2 cm); (2) 
The PD runs close to the right ventricular inflow tract and to the mid-cardiac vein, which generate 
strong and disturbing diastolic and systolic flow signals. 
                Adenosine-induced hyperventilation dedicated transducer has been designed for the LAD, 
whereas the PD is studied with a conventional imaging of the PD can be improved in several ways: (1) 
The use of ultrasound contrast agents improving the signal-to-noise ratio; (2) The use of specific A2A 
adenosine receptor agonists reducing side effects as hyperventilation; (3) The design of specific probes 
and software; (4) Reducing the heart rate to minimize wall motion artifacts on Doppler sampling. 
    Additional  piece of information in the Doppler spectrum: the intensity of the reflected signal. 
Doppler  intensity can be  used to  detect  coronary vasomotion:  it  may decrease during handgrip in 
patients with coronary artery disease  whereas it may increase or remain unchanged in normals. 
ROLE FOR THE MICROCIRCULATION 
Transthoracic coronary Doppler ultrasound has been used to study the impact on microvascular flow in 
a  number  of  settings  known  to,  or  suspected  of,  altering  microvascular  flow,  such  as  coronary 
stenting,44  remote  coronary  artery  disease,  sex  hormones,  cigarette  smoking,20  left  ventricular 
hypertrophy,22  diabetes and ageing52 53.  With regard to remote microvascular alteration in focal CAD, 
we have found that CFVR in the angiographically normal coronary artery is never affected by remote 
coronary stenosis, AMI, or stenting.55 These findings confirm that focal factors in each territory are the 
major determinants for CFVR, and impaired CFVR one region is not a general phenomenon of the 
coronary circulation. 
MONITORING  THE  CHANGES  OF  CFR  IN  THE  EARLY,  POST-PTCA  PERIOD  TO 
DETECT ARTERY OCCLUSION. 
Microvascular  stunning  due  to  microembolization,thrombogenicity  (by  thrombin  release)  and 
vasoconstriction (by endothelin release),and  temporary reactive hyperemia, a state with high post-
ischemic baseline flow velocity, masks normal reserve. Invasive CFR is obtained after multiple balloon 
inflations,  injection  of  contrast  agent  and  administration  of  vasoactive  drugs  that  may  produce 
immediatepost-procedural vasomotion instability.. Early reoclussionof the coronary artery is another 
complication after PTCA detectable by transthoracic Doppler echocardiography.
SERIAL CFR EXAMINATION AFTER PTCA TO PREDICT RESTENOSIS 
     Pierre Legalery  et al  showed that  , One-year clinical follow-up demonstrated that patients left 
with  medical  treatment  alone  had  a  similar  outcome  to  those  submitted  to  revascularization  and 
concluded  that subset of patients in whom the decision to revascularize contradicted the FFR results 
had less favourable event-free survival. 
                     Detection restenosis is feasible in mid- and long-term follow-up to monitor restenosis 37,38. 
The  decrease  of  CFR <2  during  follow-up was  proposed  as  a  sensitive  and  specific  predictor  of 
restenosis  25. This method may be complementary to exercise test, or may be its substitute if patients 
are unable to perform adequate exercise test. Besides CFR measurements distally to the  stenosis, other 
methods have been been developed to detect restenosis after PTCA.. 
CORONARY STENTING AND CFR:
                                        CFR may normalize in 80 percent of patients after stenting, corresponding to  
improved lumen area as the mechanism responsible for improved coronary blood flow. The remaining 
20 percent of patients with widely patent stents had impaired CFR (<2.0) attributed to microvascular 
disease and/or transient emboli from PCI. A low postprocedural CFR has been associated with a worse 
periprocedural outcome.
FFR after stenting also predicts adverse cardiac events at follow-up. FFR immediately after stenting 
was an independent variable related to all  adverse cardiac events. The event rate was 5 percent in 
patients in whom FFR normalized, 6 percent in patients with poststent FFR between 0.90 and 0.95, and 
20 percent in those with FFR less than 0.90. In patients with FFR less than 0.80, the event rate was 30 
percent
POSTINFARCTION CFR ASSESSMENT
   Ueno  et  al.  showed  that  the  decreased  CFR <1.5  was  identified  to  predict  an  increase  in  left 
ventricular volume (remodeling) after myocardial infarct reperfusion. A significant negative correlation 
was found between CFR and progression of left ventricular dilatation  at  6-month follow-up. 
  Colonna et al has shown that preconditioning due to pre infarction angina had a protective role on 
microvascular function as demonstrated  by CFR preservation (>2.5) after myocardial infarction.
CORONARY GRAFTS 
It is very easy to measure flow in the left and right internal mammary arteries both at the origin 46  and 
at the level of the suture over the LAD 1,2,with important perioperative and follow-up information on 
the functional status of the graft. For saphenous vein grafts it is possible to measure flow at the level of 
the suture over the LAD. 
ASSESSMENT OF CORONARY GRAFT PATENCY
 Chirillo F,  et al showed  the identification rate for mammary artery grafts was 100%, for saphenous 
vein grafts to LAD coronary artery 91%, for the vein grafts to the right coronary artery 96% and for the 
vein grafts to circumflex artery 90%43. CFR <1,9 had 100% sensitivity, 98% specificity for mammary 
artery graft stenosis. CFR <1,6 had 91% sensitivity, 87% specificity for significant vein graft stenosis.
ABSOLUTE VOLUMETRIC FLOW VERSUS FLOW VELOCITY MEASUREMENT OF CFR
Only Hozumi et al.19  achieved a very high feasibility of coronary flow imaging in their first study, i.e. 
94%. Limitation may be minimized by using echo-contrast agents enhancing Doppler signal intensity, 
which are however expensive. With regard to cost-effectiveness balance, it was calculated that using 
90-s noncontrast/adenosine vasodilator approach, the cost of the test was 14 times less expense than the 
7-min contrast-enhanced approach.
DIFFUSE ATHEROSCLEROSIS.
Coronary  arteries  without  focal  stenosis  are  generally  considered  non-flow  limiting.  A  diffusely 
diseased atherosclerotic coronary artery can be viewed as a series of branching units diverting and 
gradually distributing flow and reducing pressure longitudinally along the conduit. In such a vessel, a 
reduced CFR is not associated with any single location of stenotic pressure loss.. 
PITFALLS AND TROUBLE-SHOOTING
CFR must  be  measured  distally to  stenosis,  because  erroneous CFR assessment  at  stenosis  site  is 
underestimated due to increased baseline flow velocity.  In addition,  the flow in the LAD branches 
could be erroneously interpreted as flow in LAD main trunk.
PIONEER  WORKS  OF  NON  INVASIVE  ASSESSMENT  OF  CFR  TO  PREDICT  LAD 
STENOSIS BY TTCDE WITH ANGIOGRAPHIC COORELATION:
                  In chronological order, Lance Gould first established coronary blood flow velocity reserve 
can be measured by transthoracic ultrasound in his experimental works on  effects of coronary stenoses 
on coronary flow reserve and resistance, and in hi    s seminal work of ‘physiologic basis for assessing 
severe  coronary  stenosis:  instantaneous  flow  response  and  regional  distribution  during  coronary 
hyperemia as measures of coronary flow reserve’.   
                 Later,  Fusejima  reported that it was possible to measure coronary flow velocity in the 
midportion of the LAD with two-dimensional Doppler echocardiography, in the earlier studies  with 
65% success rates. 
        Subsequent works by  Voci  in more  than 1000 patients he established safety of adenosine 
induced vasodilation. 
      Hozumi  revealed that transthoracic CFR evaluation is useful in predicting restenosis after PCI. . 
                  Matsumura suggested  Cut-off value of coronary flow velocity reserve by transthoracic 
Doppler  echocardiography  for  diagnosis  of  significant  left  anterior  descending  artery  stenosis  in 
patients with coronary risk factors
                      Transthoracic Doppler echocardiography is noninvasive, relatively inexpensive and 
widely used in the clinical setting, and can be used for serial studies in echocardiographic laboratories.
                            Several studies have reported that CFV can be measured by visualizing LAD using 
transthoracic two-dimensional and Doppler echocardiography with a high-frequency transducer . It has 
been also  shown that CFV in the distal LAD can be measured at high success rate by TTDE under the 
guidance of color Doppler flow mapping, and assessment of CFVR in the LAD by this noninvasive 
technique is useful in the diagnosis of significant LAD stenosis . 
                                    MATERIALS AND METHODS
STUDY PATIENTS 
We have selected 59 patients who underwent coronary angiography for the evaluation of coronary 
artery disease, for chronic stable angina. They were included in this study after strictly adhering to 
study protocol.
 EXCLUSION CRITERIA
 Unstable angina 
 Congestive heart failure
 Atrial fibrillation 
 Previous coronary bypass graft surgery
 Diabetes mellitus 
Severe chronic obstructive pulmonary disease, or bronchospasm 
II–III degree atrioventricular block 
Patients with short PR intervals
Clinical history or ECG signs of a previous myocardial infarction, 
Evidence of  primary myocardial or valvular heart disease.  
Uncontrolled hypertension. 
                                                           As the microvascular dysfunction in many of situations listed 
above, especially diabetic retinopathy and unstable angina, may cause alteration in CFVR independent 
of coronary stenosis, we carefully excluded those patients from the study. 
                                                The entire patients who were included in the study were evaluated on the 
basis of proforma. Detailed history with special focus on  cardiovascular risk factors were obtained.. 
Their treatment history was noted.  All  were submitted to  thorough  physical examination,  routine 
biochemical and hematological tests , resting ECG and Treadmill Exercise stress testing with bruce 
protocol. 
  TWO DIMENSIONAL ECHOCARDIOGRAPHIC MEASUREMENTS OF LV FUNCTION 
AT BASELINE 
 Before CFVR measurements by TTDE, we measured septal and LV posterior wall thickness at end 
diastole by two-dimensional echocardiography. LV volume measurements were performed according 
to the recommendation of the American Society of Echocardiography. Apical two- and four-chamber 
views were obtained at baseline. End-diastolic and end-systolic LV volumes and Ejection fraction were 
computed by use of modified Simpson's method.. Furthermore, we assessed regional wall motion at 
rest  on  the  basis  of  16  segments  of  the  LV  as  recommended  by  the  American  Society  of 
Echocardiography. No patient had evidence of LV hypertrophy (septal or posterior wall thickness at 
diastole >12 mm) on echocardiographic examination, as LVH itself becomes an exclusion criteria for 
the study.
 Then TTCDE for measuring CFR was carried out for all patients  before coronary angiography .Those 
who had lesions in the LAD were included in this study.
COLOUR DOPPLER ECHOCARDIOGRAPHIC STUDIES
TWO –dimensional and M-mode measurements were obtained with patients in left  lateral  position 
using an ALOKA SSD4000 phased array system equipped with tissue Doppler and harmonic imaging 
technology with Doppler frequency of 2.5 to 3.8 mhz. Later it was switched over to 5mhz to 7.5mhz , 
When optimal images not obtained in individual patients.
   The acoustic window was around the midclavicular line in the fourth and fifth intercostal spaces in 
the left lateral decubitus position. First, the left ventricle was imaged in the long-axis cross section, and 
then  the  ultrasound beam was inclined laterally.   The  color  gain  was adjusted to  provide optimal 
images. Next, coronary blood flow in the distal portion of the LAD was searched under the guidance of 
color Doppler flow mapping. With a sample volume (1.5 or 2.0 mm wide) positioned on the color 
signal in the LAD, Doppler spectral tracings of flow velocity in the LAD were recorded by pulsed 
doppler. 
The spectral Doppler of the LAD flow showed a characteristic biphasic flow pattern with a larger 
diastolic component and a small systolic one. All studies were continuously recorded on 1/2 inch super-
VHS videotape for off-line analysis. 
CFVR MEASUREMENTS BY TTCDE 
We first recorded baseline spectral Doppler signals in the distal portion of the LAD. Adenosine was 
administered  (140 µg ·  kg-1  ·  min-1 IV)  for  2  minutes  to  record  spectral  Doppler  signals  during 
hyperemic conditions. All patients had continuous heart rate and ECG monitoring. Blood pressure was 
recorded at baseline, every minute during adenosine infusion, and at recovery. 
 Measurements were performed off-line by tracing the contour of the spectral Doppler signal using the 
computer incorporated in the ultrasound system. 
MDV and PDV were measured at baseline and peak hyperemic conditions. PSV was also measured at 
baseline and peak hyperemic conditions. An average of the measurements was obtained in three cardiac 
cycles.  Density  of  Doppler  spectrum was  also  noted  in  all  patients    both  at  baseline  and  after 
adenosine.
 CFR was defined as the ratio of hyperemic to basal peak diastolic coronary flow velocity (CFR PDV) 
and the ratio of hyperemic to basal mean diastolic coronary flow velocity (CFR MDV). Normal CFR 
was defined as >2.0 on the basis of previous studies that evaluated flow velocities in the distal LAD.11 
13. 
CORONARY ANGIOGRAPHY 
Reason for coronary angiography was evaluation for coronary artery disease, for chronic stable angina. 
Coronary angiogram done in the Siemens mobile unit cath lab in our hospital, and Philips mounted lab 
at  GH. Coronary angiograms  were done through right femoral approach using modified seldinger 
technique. Low osmolar nonionic contrast agent (omnipaque) was used.  Coronary angiography was 
performed with the Judkins catheters, after injection of 2500 IU IV heparin. Coronary stenosis was 
evaluated  by  use  of  multiple  projections  Quantitative  analysis  was  done  with  a  Medical  Imaging 
Systems  CMS analysis  software.  A stenosis  was  considered  significant  if  there  was  >70% lumen 
diameter narrowing in at least one projection.  Those patients with significant lesions in LAD were 
grouped as  GROUP A. Those without significant lesions in LAD were grouped as GROUP B. Those 
with significant lesions in other coronary artries were excluded. Those with severe lesions in LAD 
when lumen diameter narrowing, was more than 90%. In all the study patients, there was no significant 
stenosis (diameter stenosis >70%) in the other coronary arteries besides the LAD.
                                 RESULTS AND DATA ANALYSIS  : 
  Based on the study protocol, study patients were divided as, those patients with  significant lesions, 
>70% luminal narrowing  in proximl LAD were grouped as  GROUP A and those without significant 
lesions in proximal LAD were grouped as GROUP B for statistical  analysis.  History obtained and 
physical  findings  in  both  groups  did  not  show  much  difference.  There  was  no  difference  in  the 
distribution  of  some  of  the  variables  like,  hypertension,  smoking  ,  history  of  drug  intake  like 
asprin,enalapril,atenolol, and isosorbide dinitrate, and dyslipidemia in both groups. Routine laboratory , 
both biochemical and hematological findings  had  similar range in both groups .
Resting ECG showed  T wave changes in both groups ,but statistically not significant. Average time 
taken to perform TTDE study was 21.4 minutes. Average time taken to perform coronary angiogram 
after TTDE study, was  2.5days. Average time taken to achieve maximal coronary flow velocity was 44 
seconds.
STATISTICAL METHODS:
       Mean and SD are expressed for the baseline parametric data. The differences between the two 
groups for the parametric data were tested by use of an student independent t  test. 
Differences between baseline and hyperemic data within the two groups were tested by use of  chi 
square test.
Sensitivity, specificity, positive predictive value, and negative predictive value for CFR as a predictor 
of significant LAD stenosis were calculated in the traditional manner. 
CLINICAL AND ECHO PARAMETERS IN STUDY PATIENTS:
When baseline parameters were analysed between the two groups , no significant relationship existed 
for variables like  age, sex ,SBP,DBP,pulse rate. 
                                Mean  peak diastolic CFVR values for males were 1.363, 2.242 and for females  
1.431,  2.306  in group A and group B respectively. Mean  mean diastolic CFVR values for males were 
1.3685, 2.3219 and for females 1.4591 ,2.4400  in group A and group B respectively. 
                       When we analysed  gender influence upon  presence of LAD stenosis , distribution in 
Group A and Group B  for males 76.2% and 71.1% and for females 23.8%  28.9% respectively.Critical 
LAD stenosis more than 90% luminal narrowing was presnt in 18.9 % in females and 20.1% in males.  
                         Analysis of gender influence shows that  it is not statistically significant, though study 
population mainly consists of males(73%).
                             When comparing patients between the groups, the mean age of patient population in  
group A was 54.92 years while that of group B was, 51.43 years, not statistically significant. 
                                 Mean systolic BP was 132.37mmHg group A as against 132.10mmHg in Group B.  
While  Diastolic  Blood pressure in  group A was 85.95mmHg as  against  89.33mmHg in Group B, 
although Diastolic BP was slightly higher in group B patients than in group A, statistically it was not 
significant.
                                 We found that LV dimension in diastole and systole were normal in  all study 
patients, while  mean LVDd was 4.76cms as against 4.88cms in Group A and Group B respectively 
while that of mean LVDs was 3.32cms as against 3.33cms in Group A and Group B respectively. 
Similarly the difference in  EDV and ESV between  the two groups was not statistically significant.
                             Mean Ejection Fraction in Group A and in Group B, was 54.11 and 55.76. Similarly 
Fractional shortening(FS) was also similar in both groups, while it was 30.40  versus 31.25in Group A 
and Group B respectively. 
                                   No patient noted AV block, chest pain, flushing, or palpitations during the 
vasodilator infusion in the TTDE studies. 
HEMODYNAMICS
During adenosine administration, heart rate increased from 81.05 to 88.12 bpm in the study patients. 
Systolic arterial pressure decreased from 132.37mm Hg to 124 mmHg, and diastolic arterial pressure 
decreased from 85.95 mm Hg to 76.6 mm Hg, in Group A, and in Group B  the variations in pulse rate , 
systoloic blood pressure and diastolic blood pressure are   similar without  statistical significance .An 
increase  in  coronary flow velocity was  obtained  within  50  seconds of  the  start  of  the  vasodilator 
infusion( average: 44 sec). 
Flow  velocity  remained  stable  throughout  the  infusion  period  and  returned  to  baseline  within  30 
seconds of discontinuation of the drug. 
 Average PDV and MDV at baseline did not differ between groups A and B (23.42versus 23.18cm/s 
and 32.92 cm/s 52.39versus cm/s, respectively.
 However, average PDV and MDV during hyperemia in group A were significantly smaller than those 
in group B, p<0.001. 
There were significant  differences in  CFVR PDV and CFVR MDV measured in  groups  A and B 
(versus and versus, respectively; P<.001). 
A CFVR (PDV) < 2.0 had a sensitivity of 95%, a specificity of 86%, positive predictive value of 92%, 
and a negative predictive value of 90% for the presence of significant LAD stenosis. 
A CFVR MDV <2.0 had a sensitivity of 90%, a specificity of 91%, positive predictive value of 89%, 
and a negative predictive value of 95% for the presence of significant LAD stenosis .
When we analyzed the relationship of  TMT results  to predict presence of significant LAD stenosis, in 
our study TMT  has had a sensitivity of 82%, a specificity of 67%, positive predictive value of 79%, 
and a negative predictive value of 65% for the presence of significant LAD stenosis.   
 A cut off value 1 has very good sensitivity(96%) to predict LAD stenosis, but it has low specificity to 
predict the same( 75%). 
Peak systolic velocity as such did not have much statistical significance in our study. .Average PSV 
was 5.62 cm/s and 5.362 cm/srespectively. A  cut off value >5cm/s was tried to predict LAD stenosis 
without success. It was not significant.
 The ratio between restng PDV and PSV   was calculated and its mean value was  4.34 and 4.59 in 
patients with and without LAD stenosis. Instead hyperemic ratio between PDV and PSV  was  3.88 and 
5.17, which was statistically significant   , p value< 0.001.
ANGIOGRAPHIC FINDINGS : 
                                                          Coronary angiogram in 59 patients were reviewed with two  
different persons to quantify the lesion severity. Of 59 patients 38 persons showed significant stenosis, 
luminal diameter narrowing > 70%. Of these 27 were males and 11 were females.
                Out of the 21 patients who did not have significant LAD lesions in any of its segments 
,especially proximal, 10 patients had <40% lesions. Of these ten patients, 4 patients had entirely normal 
LAD and rest of them had luminal irregularities.
              Among the 38 patients who had significant LAD lesions, 27 patients had lesion severity less 
than 90%. Most of them had  TIMI  grade 2 flow. 
              Rest of the 11 patients had more than 90% luminal diameter narrowing severe flow limiting 
lesions. Among these, 5 patients had very severe flow limiting lesions with extensive collateral supply 
and retrofrade filling of distal and mid LAD.
           All patients who had significant stenosis, had proximal LAD lesion, while many had coexisting 
mid LAD involvement of lesser degree of involvement.
            None of the patients had significant lesion in LCX, RCA or in Ramus (which was present in 2 
of our patients), though nonsignificant lesions of varying degree was evident in most of the cases.
             Resting TIMI frame count was calculated for each patient, though no statistical analysis was 
attempted  because of  differential  reporting, since hyperemic TIMI frame count was not done in our 
study to compare with CFR.
  TABLE :1   BASELINE PARAMETRIC DATA
VARIABL
ES
 
GROUPS
With Stenosis
Without 
Stenosis
Mean SD Mean SD
Student 
independent 
t-test
age 54.92 7.93 51.43 7.65 t=1.64 P=0.11
SBP 132.37 25.07 132.10 21.94 t=0.04 P=0.97
DBP 85.95 12.78 89.33 13.07 t=0.96 P=0.34
PR 81.05 11.98 77.48 15.81 t=0.98 P=0.33
LVDd 4.76 .39 4.88 .39 t=1.07 P=0.29
LVDs 3.32 .36 3.35 .34 t=0.33 P=0.74
EF% 54.11 5.24 55.76 4.74 t=1.20 P=0.23
FS 30.40 3.72 31.25 4.58 t=0.77 P=0.44
PSV 5.62 1.30 5.36 1.68 t=0.66 P=0.58
PDV_B 23.42 1.06 23.18 .75 t=0.91 P=0.36
MDV_B 16.19 .65 15.31 1.30 t=2.90 P=0.01
PSV_M 8.82 1.77 10.23 1.17 t=3.28 P=0.01
PDV_M 32.93 7.11 52.39 6.55 t=10.34 P=0.001
MDV_M 22.55 5.16 35.81 4.21 t=10.06 P=0.001
P_CFR 1.38 .31 2.26 .27 t=10.76 P=0.001
M_CFR 1.39 .30 2.35 .31 t=11.61 P=0.001
PDV_PSV
-P 4.34 .83 4.59 .92 t=1.07 P=0.26
PDV_PSV
-M 3.88 1.05 5.17 .84 t=4.82 P=0.001
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 FIG:3.EFFICACY TO PREDICT  LAD STENOSIS: COMPARISON BETWEEN TMT AND 
CFR<2
18.4%
61.9%
81.6%
38.1%
94.7%
14.3%
5.3%
85.7%
0%
20%
40%
60%
80%
100%
%
  o
f p
at
ie
nt
s
Negative Positive <2 >2
TMT P_CFR
COMPARISON OF TMT AND CFR<2
With Stenosis
Without Stenosis
  TABLE:2. . GENDER  DIFFERENCES IN GROUP A & B
 
 
group
With Stenosis Without Stenosis
n % n % Chi-square test
sex
 
Male 27 71.1% 16 76.2%
Female 11 28.9% 5 23.8%
Group Total 38 100.0% 21 100.0%
χ2=0.18
P=0.67
Not significant
TABLE:3.  CFR<2 AS A PREDICTOR OF LAD STENOSIS
  
group
With Stenosis Without Stenosis
n % n % Chi-square test
P_CFR
 
<2 36 94.7% 3 14.3%
>2 2 5.3% 18 85.7%
Group Total 38 100.0% 21 100.0%
χ2=39.07
P=0.001
significant
M_CFR
 
<2 36 94.7% 3 14.3%
>2 2 5.3% 18 85.7%
Group Total 38 100.0% 21 100.0%
χ2=39.07
P=0.001
significant
TABLE:4.   CFR<1  AS A PREDICTOR OF CRITICL STENOSIS
 
 
group
With Stenosis Without Stenosis
n % n % Chi-square test
P_CFR
 
<1 10 26.3%  1  
>1 28 73.7% 21 100.0%
Group Total 38 100.0% 21 100.0%
χ2=6.65
P=0.01
significant
M_CFR
 
<1 9 23.7%  1  
>1 29 76.3% 21 100.0%
Group Total 38 100.0% 21 100.0%
χ2=5.86
P=0.01
significant
     
   TABLE:5.  TMT AND LAD STENOSIS
  
group
With Stenosis Without Stenosis
n % n % Chi-square test
TMT
 
Negative 7 18.4% 13 61.9%
Positive 31 81.6% 8 38.1%
Group Total 38 100.0% 21 100.0%
χ2=11.41
P=0.001
significant
             FIG 5:.  DISTRIBUTION OF CFR AND NUMBER OF PATIENTS
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TABLE:6.  PEAK AND MEAN DIASTOLIC CFR  AND PREDICTION OF LAD STENOSIS: 
GENDER INFLUENCE
group  sex N Mean Std. Deviation
Student 
independent 
t-test
With Stenosis P_CFR Male 2
7
1.363 .3437
  Female 1
1
1.431 .2319
t=0.60 
P=0.55
notsignificant
 M_CFR Male 2
7
1.368
5
.32705
  Female 1
1
1.459
1
.21305
t=0.84 
P=0.40
notsignificant
Without Stenosis P_CFR Male 1
6
2.242 .3071
  Female 5 2.306 .0493
t=0.45 
P=0.63
notsignificant
 M_CFR Male 1
6
2.321
9
.34322
  Female
5
2.440
0
.15556
t=0.73 
P=0.47
notsignificant
                                                        DISCUSSION   
It  has  been  reported  that  assessment  of  coronary  flow  reserve  by  administration  of  coronary 
vasodilators  provides  an  important  diagnostic  index  of  the  functional  significant  coronary  artery 
stenosis.1 2 3 4 5 6 
With  Doppler  technique,  coronary  flow  reserve  has  been  alternatively  assessed  as  the  ratio  of 
hyperemic  to  basal  coronary  flow  velocity  after  drug-induced  coronary  vasodilation  by  invasive 
techniques with a Doppler catheter5  6  7  8  9  or a Doppler guide wire8  9  10  11  12  13  14  because changes in 
coronary flow velocities induced by coronary vasodilation closely reflect changes in coronary blood 
flow.7 
Although these invasive methods have already been established as useful techniques, they are available 
only in the catheterization laboratories and limit the clinical application of CFVR in the assessment of 
coronary artery disease. 
Positron emission tomography has been used to measure coronary flow reserve noninvasively.33 34 35 
However, this method is expensive and not generally available. 
Several  studies  have  reported  that  transesophageal  Doppler  echocardiography  is  useful  in  the 
assessment of significant LAD stenosis by measuring hyperemic to basal coronary flow velocity in the 
proximal LAD.21 22 23 However, strictly speaking, the transesophageal approach is not noninvasive, but 
semi-invasive. 
                       TTDE is noninvasive, relatively inexpensive, and widely used in the clinical setting and 
can be used for serial studies in echocardiographic laboratories.  In the present study, we evaluated the 
value of CFVR determined by TTDE for the assessment of significant LAD stenosis after drug-induced 
coronary vasodilation. TTDE was shown to be a feasible method for the noninvasive measurement of 
CFVR and detection of significant LAD stenosis
       Fusejima24 reported that it was possible to measure coronary flow velocity in the midportion of the 
LAD with two-dimensional Doppler echocardiography, in the earlier studies  with  65% success rates. 
Subsequent works by  Voci, Hozumi, Illicito and many others, the success rate was vastly improved 
manyfold and  many innovations lead to even 100% success rate to visusalise LAD  by myocardial 
contrast enhancement.
In the present study, the success rate of the measurement of coronary flow velocity in the distal LAD 
for the assessment of CFVR was 79%, though it was lower than the values reported bymany workers. 
The moderate success rate in this study was due to the following reasons: reduction of the velocity 
range in color Doppler flow mapping and modified method to position the sample volume in the distal 
LAD under the guidance of color Doppler flow mapping. 
First, the reduction in the velocity range enhanced the visualization of the low-velocity signal in the 
distal LAD by lowering the cutoff limit of the wall motion filter. 
The velocity range in conventional color Doppler flow mapping is usually set in the range of 60 to 70 
cm/s  in  routine echocardiographic  examinations.  It  is  possible  that  use of  conventional  ultrasound 
systems that  incorporate  color  Doppler  flow mapping set  only in  the high velocity range leads  to 
difficulty in visualization of the low-velocity signals usually seen in the LAD flow. 
In our present study,  we lowered the setting of the velocity range in color Doppler flow mapping. 
Application of this newly modified velocity range in color Doppler flow mapping provided improved 
visualization of coronary flow signal in the distal LAD. 
Second,  our  method  combined  color  Doppler  flow mapping  and  the  conventional  pulsed  Doppler 
technique. This modification facilitated the positioning of the sample volume in the distal LAD flow. 
Our study demonstrated that color Doppler flow mapping enables a more efficient guidance of the 
sample volume in the distal  LAD compared with previous studies that  used only two-dimensional 
imaging. 
Under the guidance of color Doppler flow mapping, adequate spectral Doppler recordings of coronary 
flow in the distal portion of the LAD for the assessment of CFVR were obtained 59 of  75 patients who 
were   submitted  for  TTCDE  to  estmate  CFR and    those  patientsfor  whom LAD could  not  be 
visualized, were excluded for statistical analysis.  Only   59 patients were included for further statistical 
analysis. Of the 59 patients, 38 had a significant stenotic lesion in the proximal or middle portion of the 
LAD (group A; diameter stenosis >70%; 27 men, 11women; mean age, 54.92 years; the remainder did 
not have a significant stenotic lesion in the LAD (group B; 16 men, 5 women; mean age, 51.43 years). 
In our study out of 43 males 22 were smokers, While none had Diabetes, 4 had Hypertension, 11 had 
combination of risk factors such as HT and dyslipidemia, without statistical significance in distribution 
between the groups.
Baseline echo parameters were vital for interpretation of CFR since LVH, wall motion abnormalities 
and dilated LV with reduced EF can cause alterations in CFR values. In our study,for the measurement 
of LV wall thickness (septal and posterior wall), there were no significant differences between groups 
A and B (9.7±1.2 versus 9.8±1.4 mm and 10.0±1.0 versus 9.9±1.1 mm, respectively). None of the 
patients had LVH by Echocardiographic criteria. Both end-diastolic and end-systolic LV dimensions 
did not differ between groups A and B (4.76cms versus 4.88cms and 3.32cms versus 3.35, respectively) 
at baseline. There was no significant difference in ejection fraction measurement between groups A and 
B (54.11% versus 55.76%).
 In each case in both groups, segmental wall motion abnormality was not found by two-dimensional 
echocardiography at baseline. 
As the coronary physiology experimental studies reveal that every 10% increase in pulse rate ,ther is 
proportionate 15% decrease in CFR. So when we tried to analyse the influence of pulse rate upon the 
results, We found  it that mean pulse rate was, 81.05 and 77.48 in group A and group B respectively, 
statistically not significant.
                               None of our patients had developed any untoward incidents to administration of 
adenosine.  2  patients  complained  transient  chest  tightness  which  disappeared  immediately.  None 
developed   bronchopasm,  atrial  fibrillation  and  myocardial  ischemia.  Entire  study  was  under  the 
control of continous ECG monitoring and any eventuality was anticipated and was well prepared to 
meet the same.
DETECTION OF LAD STENOSIS BY CFR  
When we analyzed CFR, it is shown that most of the patients with  significant LAD stenosis,  both 
peak and mean diastolic CFVR values were hovering around 1.5 cut off value. 
We found that though CFR  > 2 effectively ruled out significant LAD stenosis,two patients had value 
more than 2. similarly, though patients with LAD stenosis had CFR value<2 most of the times, it is not 
always we could predict  lAD stenosis when the CFR value was less than 2, because in 3 patients 
without angiographic evidence of significant LAD stenosis, the CFR value was less than 2.. 
While the mean diastolic CFR had  slightly  better specificity to predict LAD stenosis , when compared 
to peak diastolic CFR has better sensitivity for the same.
    A cut off value 1 has very good sensitivity(96%) to predict LAD stenosis, but it has low sensitivity 
to predict the same( 75%). 
Peak systolic velocity as such did not have much statistical significance in our study. .Average PSV 
was 5.62 and 5.362 respectively. A  cut off value >5 was tried to predict LAD stenosis without success. 
It was not significant.
 The ratio between restng PDV and PSV   was calculated and its mean value was  4.34 and 4.59 in 
patients with and without LAD stenosis. So  the resting value was not powerful to predict LAD lesions. 
Instead hyperemic ratio between PDV and PSV  was able to predict Lad  lesion with success, p value< 
0.001.
 Very severe lesions , like  chronic total occlusion usually have collaterals to supply the mid and diastal 
LAD.  When  collaterals  feed  the  obstructed  LAD,  retrograde  blood  flow  in  mid  and  distal  LAD 
produces  diastolic flow reversal. We had recorded such diastolic flow reversal in few patients (5), and 
we tried to analyse to predict the value of  presence of diastolic flow reversal, it did not appear to 
predict the very severe lesions, though it was specific for  retrograde collateral filling  in as many cases 
it was present.
                When  we compared the Treadmill test and CFVR to predict significant LAD stenosis, CFVR 
has more beneficial results in both sensitivity and specificity.
 There were significant differences in CFVR PDV and CFVR MDV measured in groups A and B 
(versus and versus, respectively; P<.001). 
A CFVR (PDV) < 2.0 had a sensitivity of 95%, a specificity of 86%, positive predictive value of 92%, 
and a negative predictive value of 90% for the presence of significant LAD stenosis. 
A CFVR MDV <2.0 had a sensitivity of 90%, a specificity of 91%, positive predictive value of 89%, 
and a negative predictive value of 95% for the presence of significant LAD stenosis .
The transthoracic approach is completely noninvasive. The higher success rate in the assessment of 
CFR and the fact  that  it  is a noninvasive procedure should be important advantages in the present 
transthoracic method. 
LIMITATIONS 
CFVR is defined as a flow velocity ratio, regardless of the concomitant pressure gradient or of the 
absolute values of flow. Its value inherently depends on frequently independent variations in baseline 
or maximal flow that may be caused by factors unrelated to stenosis severity. Hence, the limitation to 
only 1 of 2 interdependent signals, pressure or flow velocity, may be a source for potential inaccuracies 
in  the  assessment  of  functional  stenosis  severity  for  diagnostic  purposes  by  CFVR.  Furthermore, 
determination of both CFVR and FFR critically depends on the achievement of maximal vasodilation
However, with the currently available technology, transthoracic coronary Doppler ultrasound cannot 
detect branch stenosis; 
We measured changes in coronary flow velocity, not changes in coronary blood flow. However, it has 
been reported that changes in coronary flow velocities induced by coronary vasodilation closely reflect 
changes in coronary blood flow.5 
Previous  studies  with  Doppler  catheter,  Doppler  guide  wire,  and  transesophageal  Doppler 
echocardiography have shown that these techniques are useful in the prediction of significant coronary 
artery stenosis by the assessment of coronary flow velocity.11 12 13 14 15 16 17 18 .
Second, we measured CFVR from only diastolic mean velocities, not mean velocities throughout the 
entire cardiac cycle.  It  was difficult  to  obtain complete Doppler spectral  envelopes throughout the 
entire cardiac cycle because of cyclic cardiac motion.. However, diastolic component of the spectral 
Doppler signal of the LAD flow could be clearly obtained by positioning the sample volume in the 
LAD during the diastolic phase under the guidance of color Doppler flow mapping. 
Third, in the present study, there was only a small number of patients with significant coronary stenosis 
in the LAD. In future investigations, more patients should be studied by the present method. 
In  the  present  study,  we  excluded  several  factors  influencing  CFR  measurement  such  as  LV 
hypertrophy and myocardial infarction. However, other potential determinants of CFR that were not 
measured and were not excluded in this study may affect the sensitivity and specificity for the presence 
of significant LAD stenosis in the present method. 
                                                     
                                   CONCLUSIONS                                       
 . In the present study, the success rate of the measurement of coronary flow velocity in the LAD for 
the assessment of CFVR was over 79% of patients. 
2. Both  Peak and  Mean   diastolic velocity  based  CFVR <2  correlated well with angiographic 
evidence of significant stenosis in LAD.
3. A CFVR (PDV) < 2.0 had a sensitivity of 95%, a specificity of 86%, positive predictive value of 
92%, and a negative predictive value of 90% for the presence of significant LAD stenosis in this study. 
4.  CFVR<2  has statistically significant  better correlation with angiographic evidence of significant 
stenosis in LAD  in comparison with TMT positivity.
5.  This study shows that CFVR  correlates well with the angiographic degree of the stenosis. CFVR 
<1 has significant correlation to predict very severe LAD stenosis.
6. It is shown in our study that  Peak SystolicVelocity >5 cm  did not correlate with the presence of 
critical LAD Stenosis. .The hyperemic PDV/PSV  ratio has statistical significance to predict  LAD 
lesion in our study, while basal ratio did not.
8.TTCDE   assessment of CFVR  is safe. No complications observed  in our study.
9.  Reverse diastolic flow at rest,  reflecting retrograde filling of the artery by collaterals,  is a very 
specific marker of coronary occlusion  but it unfortunately has a low sensitivity
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                                              PROFORMA
NON  INVASIVE  ASSESSMENT  OF  CORONARY  FLOW  VELOCITY 
RESERVE  WITH  TRANSTHORACIC  COLOUR  DOPPLER 
ECHOCARDIOGRAPHY  TO  PREDICT  SIGNIFICANT  LEFT  ANTERIOR 
DESCENDING CORONARY ARTERY STENOSIS NAME :
AGE : SEX :
OCCUPATION : C.D. NO. :                           ADDRESS :     
RISK FACTOR PROFILE :
HYPERTENSION SMOKING OBESITY (BMI)
HYPERLIPIDEMIA PREVIOUS CAD               DM/ RETINOPATHY
CLINICAL PROFILE :
CHEST PAIN CCS CLASS            VITAL PARA METERS :       P R :        BP
CVS                                    RS                              OTHER SYSTEMS
DRUGS USED
 ASPRIN                   ISDN                 ACEI                                B.BLOCKER
 INVESTIGATION :
BLOOD SUGAR : CARDIAC ENZYMES :                  CHEST  X RAY  PA  :
ECG :           LVH                PR INTERVAL                       AF                     DELTA WAVES
ECHOCARDIOGRAPHY :  SYSTOLIC FUNCTION : LV DIMENSION :   LVIDd : LVIDs: 
EDV : ESV : EF :              FS : RWMA :    WALL THICKNESS
DIASTOLIC FUNCTION :    TRANS MITRAL FLOW PATTERN : E             A
TTCDE  EXAMINATION OF MID  AND  DISTAL LAD
COLOUR FLOW STUDY 
 1.LAD VISUALISED                     2. TURBULENT COLOUR FLOW  IN LAD
3.VISIBLE PERFORATORS             4.DIASTOLIC FLOW REVERSAL
DOPPLER STUDY:                                         BASAL                                      HYPEREMIC
1. PEAK SYSTOLIC  VELOCITY
2. PEAK DIASTOLIC VELOCITY                          
3. MEAN DIASTOLIC VELOCITY
4.DOPPLER DENSITY CHANGE
5.DIASTOLIC FLOW REVERSAL.
HEMODYNAMIC CHANGES                 
 1.PULSE RATE
2.SYSTOLIC BP
 3.DIASTOLIC BP
COMPLICATIONS
1.PALPITATIONS             2.CHEST TIGHTNESS            3.MYOCARDIAL ISCHEMIA
4.ATRIAL FIBRILLATION             5.WHEEZE           6.AV  BLOCK
CORONARY ANGIOGRAM :
LMCA                            LCX :                             RCA :                          RAMUS 
LAD :
COLLATERELS WITH RETROGRADE FILLING OF  LAD  .          
                                            
                                               
                                           GLOSSARY
TTCDE :         TRANSTHORACIC COLOUR DOPPLER ECHOCARDIOGRAPHY.
CFVR:             CORONARY FLOW VELOCITY RESERVE
PDV:                PEAK DIASTOLIC VELOCITY
MDV :               MEAN  DIASTOLIC VELOCITY
LVDd : LEFT VENTRICULAR INTERNAL DIMENSION IN DIASTOLE
LVDs : LEFT VENTRICULAR INTERNAL DIMENSION IN SYSTOLE
CHD : CORONARY HEART DISEASE
DM : DIABETES MELLITUS
LVH : LEFT VENTRICULAR HYPERTROPHY
MI : MYOCARDIAL INFARCTION
EF : EJECTION FRACTION
EDV : END-DIASTOLIC VOLUME
ESV : END-SYSTOLIC VOLUME
LVEF : LEFT VENTRICULAR EJECTION FRACTION
CCS : CANADIAN CARDIAC SOCIETY 
AMI : ACUTE MYOCARDIAL INFARCTION
LAD : LEFT ANTERIOR DESCENDING ARTERY
LCX : LEFT CIRCUMFLEX ARTERY
RCA : RIGHT CORONARY ARTERY
LMCA: LEFT MAIN CORONARY ARTERY
